Effects of calcitonin on knee osteoarthritis and quality of life
- PMID: 22453526
- DOI: 10.1007/s00296-012-2399-z
Effects of calcitonin on knee osteoarthritis and quality of life
Abstract
There has been a recent interest in calcitonin as a potential treatment for osteoarthritis, based on its metabolic activities in both bone turnover and cartilage. The aim of this study was to evaluate the effects of nasal form calcitonin on knee osteoarthritis and quality of life in women who receive calcitonin treatment for postmenopausal osteoporosis. Two hundred and twenty postmenopausal women, aged between 55 and 65 years with knee pain and knee osteoarthritis, graded II-III by using Kellgren-Lawrence radiographic scoring system, were included. Western Ontario and McMaster Universities (WOMAC) osteoarthritis index, the quality of life questionnaire of the European Foundation for Osteoporosis (QALEFFO-41) and visual analog scale were used for the algofunctional assessments. Need of rescue analgesic was recorded. Pain (P < 0.001), stiffness (P < 0.05), functional capability (P < 0.05) and total score of WOMAC (P < 0.05) revealed statistically significant improvements after 3 months of the treatment and remained consistent throughout 1 year of the treatment period. Participants experienced significant reductions in WOMAC perceptions of pain (-53 %), joint stiffness (-44 %) and limitations in physical function (-49 %) at the end of 1 year of calcitonin treatment. Need of rescue analgesic intake was reported to have decreased approximately by 60 % at the end of the 1-year treatment period. QUALEFFO_41 scores improved: 37.6 (baseline), 30.9 (3 months), 28.0 (6 months) and 24.4 (1 year). In conclusion, nasal calcitonin treatment provided dual action on osteoporosis and osteoarthritis with significant improvements in quality of life and algofunctional results in knee osteoarthritis.
Similar articles
-
Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.Osteoarthritis Cartilage. 2015 Apr;23(4):532-43. doi: 10.1016/j.joca.2014.12.019. Epub 2015 Jan 9. Osteoarthritis Cartilage. 2015. PMID: 25582279 Clinical Trial.
-
Inhalation therapy of calcitonin relieves osteoarthritis of the knee.J Korean Med Sci. 2012 Nov;27(11):1405-10. doi: 10.3346/jkms.2012.27.11.1405. Epub 2012 Oct 30. J Korean Med Sci. 2012. PMID: 23166425 Free PMC article. Clinical Trial.
-
Clinical effect of intramuscular calcitonin compared with oral celecoxib in the treatment of knee bone marrow lesions: a retrospective study.J Orthop Surg Res. 2020 Jun 23;15(1):230. doi: 10.1186/s13018-020-01746-y. J Orthop Surg Res. 2020. PMID: 32576210 Free PMC article.
-
Platelet-Rich Plasma Combined With Hyaluronic Acid Improves Pain and Function Compared With Hyaluronic Acid Alone in Knee Osteoarthritis: A Systematic Review and Meta-analysis.Arthroscopy. 2021 Apr;37(4):1277-1287.e1. doi: 10.1016/j.arthro.2020.11.052. Epub 2020 Dec 3. Arthroscopy. 2021. PMID: 33278533
-
Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.Drugs Aging. 1996 May;8(5):378-400. doi: 10.2165/00002512-199608050-00006. Drugs Aging. 1996. PMID: 8935399 Review.
Cited by
-
Efficacy of Intramuscular Injection of Calcitonin on Pain Functional Status of Patients with Knee Osteoarthritis.Anesth Pain Med. 2023 Mar 9;13(2):e133992. doi: 10.5812/aapm-133992. eCollection 2023 Apr. Anesth Pain Med. 2023. PMID: 37601958 Free PMC article.
-
Future directions for the management of pain in osteoarthritis.Int J Clin Rheumtol. 2014 Apr;9(2):197-276. doi: 10.2217/ijr.14.10. Int J Clin Rheumtol. 2014. PMID: 25018771 Free PMC article.
-
The dual amylin and calcitonin receptor agonist KBP-336 elicits a unique combination of weight loss, antinociception and bone protection - a novel disease-modifying osteoarthritis drug.Arthritis Res Ther. 2024 Jul 12;26(1):129. doi: 10.1186/s13075-024-03361-2. Arthritis Res Ther. 2024. PMID: 38997785 Free PMC article.
-
Loss of parafollicular cells during gravitational changes (microgravity, hypergravity) and the secret effect of pleiotrophin.PLoS One. 2012;7(12):e48518. doi: 10.1371/journal.pone.0048518. Epub 2012 Dec 19. PLoS One. 2012. PMID: 23284618 Free PMC article.
-
Osteoarthritis: Pathology, Mouse Models, and Nanoparticle Injectable Systems for Targeted Treatment.Ann Biomed Eng. 2016 Jun;44(6):2062-75. doi: 10.1007/s10439-016-1600-z. Epub 2016 Apr 4. Ann Biomed Eng. 2016. PMID: 27044450 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources